The 20 Best Retinal Artery Occlusion Doctors near Jersey City, NJ

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Doyne Honeycomb Retinal Dystrophy, and Cone Dystrophy.

Louis Angioletti is an Ophthalmologist in New York, New York. Dr. Angioletti is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Retinal Vein Occlusion.

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Dr. Fisher is a clinical ophthalmologist specializing in vitreoretinal diseases. Dr. Fisher’s career is noteworthy in the areas of patient care, teaching, and research. He is the author of several textbooks in the field of vitreoretinal diseases and ultrasonography.AuthorDr. Fisher has published more than 50 scientific articles and numerous scientific exhibits and posters. He was a course director for the American Academy of Ophthalmology for over 22 years and a review editor for many prestigious ophthalmic journals. He has received numerous awards for national and international professorships and lectureships. He has also been awarded the coveted Senior Award from the American Academy of Ophthalmology.LecturesDr. Fisher has lectured throughout the United States and abroad in the areas of ultrasonography and vitreoretinal surgery, developing new techniques and instruments in his field as well as pioneering developments in ocular endoscopy. He was selected by departmental chairmen and section chiefs at major ophthalmology centers nationwide as one of the 400 best retina doctors in America.Developed InstrumentsDr. Fisher has developed numerous intraocular surgical instruments which have advanced the field of vitreoretinal surgery. These instruments include electromagnets as well as endoscopic techniques for situations where microscopic visualization is limited or impossible. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Adult-Onset Vitelliform Macular Dystrophy (AVMD), Age-Related Macular Degeneration (ARMD), Retinal Detachment, and Vitrectomy.

David Berman is an Ophthalmologist in Brooklyn, New York. Dr. Berman is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Retinal Vein Occlusion, Retinal Artery Occlusion, Diabetic Retinopathy, and Retinal Detachment.

Jason Slakter is an Ophthalmologist in New York, New York. Dr. Slakter is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Retinal Detachment, and Vitrectomy.

Practice limited to diseases of the retina and vitreous. Special interest in diagnosis and treatment of macular degeneration, diabetic retinopathy, and retinal tears. Research interest in pseudoxanthoma elasticum complicated by angioid streaks. Dr. Fuchs is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Central Serous Chorioretinopathy, and Retinal Vein Occlusion.

Susan Fromer is an Ophthalmologist in New York, New York. Dr. Fromer is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Glaucoma, Kallikrein Hypertension, Allergic Conjunctivitis, and Meibomianitis.

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy.

Marco Zarbin is an Ophthalmologist in Newark, New Jersey. Dr. Zarbin is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Endophthalmitis, Retinal Detachment, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Trabeculectomy.

Danielle Strauss is an Ophthalmologist in Bloomfield, New Jersey. Dr. Strauss has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Detachment.

Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, Macular Degeneration, Macular Holes, Macular Pucker, Diabetic Retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the diagnosis and treatment of Retinal Diseases. He has given lectures around the world.He has a remarkable number of “firsts” in retinal diseases including the development of autofluorescence imaging using a fundus camera and the first practical method to image deeper structures in the eye with optical coherence tomography. These imaging methods now are used around the world. He has described many new findings and diseases of the eye and helped develop many novel treatments. He has developed numerous surgical instruments that were named after him and holds patents for ophthalmic inventions.He is the recipient of the Richard and Hilda Rosenthal Foundation Award in the Visual Sciences, the Senior Honor Award from the American Society of Retinal Surgeons, and the Senior Achievement Award from the American Academy of Opthalmology and the Prix Soubrane de la Recherche en Ophthalmologie, Award of Merit from the Retina Society, the Henkind Award, Coscas Award, Nataraja Pillai Award, W. Richard Green MD Award, George Theodossiadis Award, Founders Award, American Society of Retinal Surgeons, Life Achievement Honor Award, and the American Academy of Ophthalmology. Dr. Spaide is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Geographic Atrophy, and Vitrectomy.

K. Bailey Freund, MD specializes in diagnosis, treatment and care of patients with all retinal disorders including macular degeneration, diabetic retinopathy, and retinal vascular and inflammatory diseases and is an expert in difficult-to-diagnose and rare conditions. He has been at the forefront of pivotal national clinical trials as a principal investigator for treatments for retinal diseases, providing his patients access to the latest solutions and remedies utilizing the most state of the art diagnostic equipment.Dr. Freund is internationally recognized in his field and is a member of the Retina Society, Macula Society, and the American Society of Retina Specialists. He is on the Editorial Board of the journal Retina and is an Associate Editor for Retinal Cases & Brief Reports. He has authored over 250 peer-reviewed scientific manuscripts and has written numerous book chapters. He has received numerous awards including the prestigious Young Investigator Award from the Macula Society.He is a graduate of Williams College and the New York University School of Medicine and completed his residency training in general ophthalmology and fellowship in medical and surgical retina at the Manhattan Eye, Ear, and Throat Hospital. Dr. Freund was born and raised in Manhattan and continues to reside here with his wife and his two children. Dr. Freund enjoys playing the guitar and is a prominent collector of vintage magic apparatus. Dr. Freund is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Choroid Plexus Carcinoma.

Michael Engelbert, MD, PhD, a vitreoretinal surgeon and macular disease specialist, provides both medical care for age-related macular degeneration and diabetic eye disease as well as surgical management of macular disease and retinal detachment repair, including complex detachments from diabetes and after trauma or failed primary repair. He also specializes in secondary intraocular lens implantation after complicated cataract surgery. He is an internationally renowned expert on vitreous anatomy and vitreoretinal interface disorders, topics on which he lectures at home and abroad.Dr. Engelbert received his medical degree Magna Cum Laude from Ludwig-Maximilians-University in Munich, Germany, after which he dedicated himself several years to basic research in the study of endophthalmitis, a vision-threatening infection, that can occur after eye surgery. He earned a Ph.D. for this work and is considered a leader in this field.Before joining the residency program at Columbia University, Dr. Engelbert served his internship at Griffin Hospital, a Yale-affiliated center in Connecticut, where he was granted the Vincent D. DeLuca award for the best medical intern.Afterward, he was resident and chief resident in the Department of Ophthalmology of Columbia University’s College of Physicians and Surgeons at the Edward S. Harkness Eye Institute on the Columbia Presbyterian Medical Center Campus. Following his residency training, Dr. Engelbert was awarded a medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University.Dr. Engelbert is a member of The American Society of Retina Specialists (ASRS), The European Society of Vitreoretinal Specialists (EVRS), the Association for Research in Vision and Ophthalmology (ARVO), and The American Academy of Ophthalmology (AAO) and the prestigious Club Jules Gonin. He has published numerous papers on retinal disease, received several awards and has been granted permanent resident status in the United States in the category “outstanding scientist”. He serves as a reviewer for the premier journals in the field, including the Archives of Ophthalmology, Ophthalmology, Investigative Ophthalmology and Visual Sciences, Retina, Eye, and Graefe’s Archives of Clinical and Experimental Ophthalmology.He is a Research Assistant Professor at New York University and Clinical Instructor at NYU , where he is actively involved in instructing residents and fellows in the art of medical retina and retinal surgery, and provides care for an underserved population with often advanced disease requiring complex surgical intervention. Dr. Engelbert is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Iridectomy.

Dr. Klancnik utilizes all forms of ophthalmic imaging including fluorescein angiography, indocyanine green angiography, as well as noninvasive forms of imaging such as spectral domain optical coherence tomography, autofluorescence photography, and ultrasonography.Dr. Klancnik is a magna cum laude graduate of Yale University. He earned his medical degree from Jefferson Medical College of Thomas Jefferson University and was elected to the Alpha Omega Alpha and Hobart Amory Hare honor medical societies. He completed his internship at the Lankenau Hospital and his ophthalmology residency at Wills Eye Hospital. He completed his medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University. He is an Assistant Professor of Clinical Ophthalmology at New York University School of Medicine.Dr. Klancnik is a member of numerous medical organizations including the American Academy of Ophthalmology, American Society of Retinal Specialists, and Association for Research in Vision and Ophthalmology. He is an author of numerous peer-reviewed journal articles and book chapters and has presented at scientific meetings nationally and internationally. He is active in numerous clinical trials as principle or sub-investigator and serves as a reviewer for several ophthalmology journals. Dr. Klancnik is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Vein Occlusion.

Irene A. Barbazetto, M.D. is a vitreoretinal surgeon and macular disease specialist board certified in the United States and Europe. She is an internationally recognized expert in the treatment of macular degeneration, retinal vascular disease, retinal vein occlusion, hereditary retinal disease, and diabetes.The author of more than 40 peer-reviewed articles and book chapters, she serves on the Editorial Board of the prestigious journal Graefe’s Archive of Clinical and Experimental Ophthalmology. Dr. Barbazetto is the recipient of the 2009 Achievement Award from the American Academy of Ophthalmology. Her patients voted her as one of the best retina doctors, America’s “Most Compassionate Physicians,” and she received the “Patient’s Choice Award” in 2010. A graduate of Hamburg University, Germany, Dr. Barbazetto’s doctoral thesis investigated a newly developed vision-screening test (H-Test) for pre-school children and was awarded cum laude. She completed her ophthalmology residency in Lübeck, Germany, where she participated in the development of photodynamic therapy for the treatment of macular degeneration.In 2000, she came to New York for a research fellowship with Dr. Stanley Chang at Columbia University, focusing on the role of oxygen in the development of cataract after vitreoretinal surgery. She completed an internship in general surgery at the Lenox Hill Hospital in Manhattan and an ophthalmology residency at Columbia University. Dr. Barbazetto is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Adult-Onset Vitelliform Macular Dystrophy (AVMD).

Armand Fasano is an Ophthalmologist in West New York, New Jersey. Dr. Fasano is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Optic Atrophy Type 1, Optic Nerve Atrophy, Neurotrophic Keratitis, and Cataract.

"William M. Schiff, MD is a board certified Ophthalmologist, specializing in the medical and surgical management of vitreous and retinal diseases. He is the Director of Ophthalmic Surgery at Manhattan Eye Ear and Throat Hospital (MEETH) and serves an educational role as the Co-Director of the Vitreoretinal Fellowship Program. Dr. Schiff's practice encompasses the management of medical and surgical diseases of the vitreous, retina, and macula including macular degeneration, macular hole, epiretinal membrane, diabetic retinopathy and retinal detachment. Dr. Schiff was previously Professor of Clinical Ophthalmology at Columbia University, College of Physicians and Surgeons. He has lectured widely, has authored or coauthored more than 50 publications, and is an active member of numerous professional societies and organizations including The American Academy of Ophthalmology, The Retina Society, The American Society of Retinal Specialists and the New York Ophthalmologic Society. Dr. Schiff has earned the Achievement Award from the American Academy of Ophthalmology and the Honor's Award from the American Society of Retina Specialists. He has been named in ""New York Magazine's Best Doctors,"" Castle Connolly's ""America's Top Doctors"" and Castle Connolly's ""Top Doctors in the New York Metro Area.""". Dr. Schiff is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, Vitrectomy, and Cataract Removal.

Dr. Barile is Professor of Ophthalmology, Zucker School of Medicine at Hofstra /Northwell, and Director of Ophthalmology Research, Manhattan Eye, Ear and Throat Hospital. He previously served as the John Wilson Espy MD Professor of Clinical Ophthalmology and Glaubinger Scholar in Retina Research at Columbia University. Dr. Barile has lectured widely, has authored or coauthored more than eighty publications, and is a member of numerous professional societies and organizations including the Macula and Retina Societies. Among several honors, Dr. Barile received an Achievement Award from the American Academy of Ophthalmology and a Senior Honor Award from the American Society of Retina Specialists. Dr. Barile is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, Retinal Vein Occlusion, and Vitrectomy.

Naomi Goldberg is an Ophthalmologist in New York, New York. Dr. Goldberg is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Scleritis, and Neuroretinitis.